Comment on Tang et al. The Impact of Carbamylation and Anemia on HbA 1c ’s Association With Renal Outcomes in Patients With Diabetes and Chronic Kidney Disease. Diabetes Care 2023;46:130–137

We were interested in the recent article inDiabetes Care from Tang et  al. (1), in which they reported that lower HbA1c in subjects with highly carbamylated albumin (C-Alb) was not clearly related to glucose levels, precluding a relationship of HbA1c with the later progression of chronic kidney disease.
Source: Diabetes Care - Category: Endocrinology Source Type: research